Morgan Stanley’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $60.5M | Buy |
4,314,530
+475,989
| +12% | +$6.67M | ﹤0.01% | 1744 |
|
|
2025
Q1 | $60M | Sell |
3,838,541
-405,370
| -10% | -$6.34M | ﹤0.01% | 1652 |
|
|
2024
Q4 | $59.1M | Buy |
4,243,911
+462,716
| +12% | +$6.45M | ﹤0.01% | 1685 |
|
|
2024
Q3 | $35.2M | Sell |
3,781,195
-191,499
| -5% | -$1.78M | ﹤0.01% | 2204 |
|
|
2024
Q2 | $36.9M | Sell |
3,972,694
-33,641
| -0.8% | -$313K | ﹤0.01% | 2037 |
|
|
2024
Q1 | $39.7M | Sell |
4,006,335
-8,159,809
| -67% | -$80.9M | ﹤0.01% | 1966 |
|
|
2023
Q4 | $39.3M | Buy |
12,166,144
+11,944,104
| +5,379% | +$38.6M | ﹤0.01% | 2704 |
|
|
2023
Q3 | $1.18M | Sell |
222,040
-263,938
| -54% | -$1.4M | ﹤0.01% | 4702 |
|
|
2023
Q2 | $4.63M | Buy |
485,978
+148,324
| +44% | +$1.41M | ﹤0.01% | 3834 |
|
|
2023
Q1 | $3.71M | Buy |
337,654
+139,590
| +70% | +$1.54M | ﹤0.01% | 4025 |
|
|
2022
Q4 | $2.93M | Buy |
198,064
+73,138
| +59% | +$1.08M | ﹤0.01% | 4189 |
|
|
2022
Q3 | $2.39M | Buy |
124,926
+16,757
| +15% | +$320K | ﹤0.01% | 4297 |
|
|
2022
Q2 | $2.3M | Buy |
108,169
+10,717
| +11% | +$228K | ﹤0.01% | 4420 |
|
|
2022
Q1 | $1.88M | Buy |
97,452
+44,433
| +84% | +$856K | ﹤0.01% | 4561 |
|
|
2021
Q4 | $1.1M | Sell |
53,019
-90,727
| -63% | -$1.88M | ﹤0.01% | 5001 |
|
|
2021
Q3 | $3.43M | Sell |
143,746
-82,927
| -37% | -$1.98M | ﹤0.01% | 4093 |
|
|
2021
Q2 | $6.19M | Buy |
226,673
+100,961
| +80% | +$2.75M | ﹤0.01% | 3558 |
|
|
2021
Q1 | $3.64M | Sell |
125,712
-26,298
| -17% | -$761K | ﹤0.01% | 3742 |
|
|
2020
Q4 | $4.28M | Buy |
152,010
+149,207
| +5,323% | +$4.2M | ﹤0.01% | 3423 |
|
|
2020
Q3 | $83K | Sell |
2,803
-770
| -22% | -$22.8K | ﹤0.01% | 5511 |
|
|
2020
Q2 | $108K | Buy |
3,573
+2,136
| +149% | +$64.6K | ﹤0.01% | 5371 |
|
|
2020
Q1 | $43K | Buy |
+1,437
| New | +$43K | ﹤0.01% | 5522 |
|